Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study). [electronic resource]
Producer: 20080723Description: 385-9 p. digitalISSN:- 1755-3768
- Adult
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Cell Division -- drug effects
- Combined Modality Therapy
- Diabetic Retinopathy -- drug therapy
- Female
- Follow-Up Studies
- Humans
- Injections
- Laser Coagulation -- methods
- Male
- Middle Aged
- Prospective Studies
- Risk Factors
- Treatment Outcome
- Visual Acuity
- Vitreous Body
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.